Tetratherapeutics
Florham Park, US · 1 known investors
Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
Investors · 1
Frequently asked questions
- What does Tetratherapeutics do?
- Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
- Who are Tetratherapeutics's investors?
- Tetratherapeutics's investors include Invest Michigan.
- Where is Tetratherapeutics headquartered?
- Tetratherapeutics is headquartered in Florham Park, US.